Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

VYNE Therapeutics (VYNE) Tax Provisions (2019 - 2024)

VYNE Therapeutics' Tax Provisions history spans 5 years, with the latest figure at $4000.0 for Q4 2024.

  • For Q4 2024, Tax Provisions changed N/A year-over-year to $4000.0; the TTM value through Jun 2025 reached $4000.0, changed N/A, while the annual FY2025 figure was $4000.0, 0.0% changed from the prior year.
  • Tax Provisions reached $4000.0 in Q4 2024 per VYNE's latest filing, down from $13000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $13000.0 in Q4 2022 to a low of -$448000.0 in Q4 2021.
  • Average Tax Provisions over 4 years is -$137800.0, with a median of $1000.0 recorded in 2020.
  • The largest YoY upside for Tax Provisions was 102.9% in 2022 against a maximum downside of 102.9% in 2022.
  • A 4-year view of Tax Provisions shows it stood at $1000.0 in 2020, then tumbled by 44900.0% to -$448000.0 in 2021, then soared by 102.9% to $13000.0 in 2022, then crashed by 69.23% to $4000.0 in 2024.
  • Per Business Quant, the three most recent readings for VYNE's Tax Provisions are $4000.0 (Q4 2024), $13000.0 (Q4 2022), and -$448000.0 (Q4 2021).